# OnCo record nct07285148 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07285148/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07285148", "NCT07285148" ;
  schema:name "A Study to Evaluate ANS014004 in Combination With EGFR-TKI in Non-Small Cell Lung Cancer"@en ;
  schema:description "A phase 1/2 trial of osimertinib in lung cancer, run by Beijing Pearl Biotechnology Limited Liability Company, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07285148/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07285148> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "lung-deep-dive" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/egfr-mutant-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/osimertinib/> ;
  onco:companies <https://onco.cc/companies/beijing-pearl-biotechnology-limited-liability-company/>, <https://onco.cc/companies/avistone-biotechnology/> .